<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It has long been known that <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> are linked </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, it has been shown that adipocytes secrete several proteins including <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha, interleukin-6, resistin, and adiponectin </plain></SENT>
<SENT sid="2" pm="."><plain>Since several of these so-called adipocytokines influence insulin sensitivity and <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism profoundly, they might provide a molecular link between <z:mp ids='MP_0010024'>increased adiposity</z:mp> and impaired insulin sensitivity </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="50864">Thiazolidinediones</z:chebi> which decrease <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and are used in the treatment of Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> seem to mediate part of their insulin-sensitising effects via modulation of adipocytokine expression </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, hormones such as <z:chebi fb="0" ids="35522">beta-adrenergic agonists</z:chebi>, insulin, <z:chebi fb="1" ids="24261">glucocorticoids</z:chebi>, and growth hormone might impair insulin sensitivity at least in part via up-regulation or down-regulation of adipocytokine synthesis </plain></SENT>
<SENT sid="5" pm="."><plain>We summarise the current knowledge on how major adipocyte-secreted proteins are regulated by hormones and drugs influencing insulin sensitivity and discuss its implications for <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
</text></document>